Camber Capital Management LP Pfizer Inc Call Options Transaction History

Camber Capital Management LP

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $36.8 Million - $42.2 Million	-1,420,000 Reduced 36.22%	2,500,000 $69.4 Million
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $93.5 Million - $122 Million	-3,580,000 Reduced 47.73%	3,920,000 $113 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $241 Million - $281 Million	7,500,000 New	7,500,000 $249 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $109 Million - $134 Million	2,500,000 New	2,500,000 $109 Million
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $78.5 Million - $101 Million	-2,000,000 Closed	0 $0

Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $71.8 Million - $81.4 Million	2,000,000 New	2,000,000 $78.3 Million

3,159

3.68B

67.4M

113M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Camber Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Camber Capital Management LP with notifications on news.